Key result
Anakinra successfully treated refractory SLE-related pericarditis in a 30-year-old man, resulting in no pericarditis or fever over 12 months of follow-up.
Why the study?
Does anakinra improve refractory pericarditis in a patient with systemic lupus erythematosus?
Case Report (n=1)
No
Does anakinra improve refractory pericarditis in a patient with systemic lupus erythematosus?
Anakinra successfully treated a case of refractory SLE-related pericarditis, suggesting IL-1 targeting may be an effective strategy when conventional immunosuppressants fail.
None
No takes yet. Share an insight, caveat, or question.
Cafarelli et al. (2021) conducted a case report in Systemic lupus erythematosus with refractory pericarditis (n=1). Anakinra was evaluated on Pericarditis relapse and fever. Anakinra successfully treated refractory SLE-related pericarditis in a 30-year-old man, resulting in no pericarditis or fever over 12 months of follow-up.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: